Strong leadership marred by post-merger confusion - werkgeversreview Research Associate bij SpringWorks Therapeutics

4,0
15 apr 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Innovative, robust leadership, community values

Minpunten

Post merger confusion led to more problems in daily workflows

Ontdek andere reviews over SpringWorks Therapeutics

5,0
1 feb 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

The culture- hype is real. Hands down, best culture I’ve ever worked in. Lets hope EMDS/ Merck KGaA doesn’t ruin it.

Minpunten

The acquisition has been tough. Feels like we’ve joined a sinking ship. A lot of meetings, but real work doesn’t get done.

5,0
23 jul 2025
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Remote, independent work; dedicated coworkers

Minpunten

Resources as expected for midsize (capabilities/amenities of large pharma are not available)

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle